Brief: Fresh Tracks Therapeutics Board Terminates CEO Andrew Sklawer
19/09/2023 22:41
Sept 19 (Reuters) - Fresh Tracks Therapeutics Inc
FRTX.O :
* FRESH TRACKS THERAPEUTICS- ON SEPT 18, BOARD TERMINATED
ANDREW
D. SKLAWER, CO’S PRESIDENT & CEO EFFECTIVE OCTOBER 2, 2023
* FRESH TRACKS THERAPEUTICS- APPOINTED ALBERT N. MARCHIO,
II, CO’S
CURRENT CFO, AS CO’S NEW CEO, CFO, SECRETARY, AS WELL AS
DIRECTOR & CHAIRMAN OF BOARD
Further company coverage: FRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx